LEADER 01728nam  2200421Ia 450 
001 9910698838703321
005 20090521103131.0
035   $a(CKB)5470000002397480
035   $a(OCoLC)334196478
035   $a(EXLCZ)995470000002397480
100   $a20090521d2004      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $erecommendations for obtaining a labeling claim for communicable disease donor screening tests using cadaveric blood speciments from donors of human cells, tissues and cellular and tissue-based products (HCT/Ps)
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,$d[2004]
215   $ai, 7 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on May 21, 2009).
300   $a"November 2004".
320   $aIncludes bibliographical references (page 7).
517   $aGuidance for industry 
606   $aBlood$xExamination$zUnited States
606   $aCell culture$zUnited States$xTesting
606   $aDonation of organs, tissues, etc$zUnited States$xTesting
606   $aCommunicable diseases$zUnited States$xPrevention
615  0$aBlood$xExamination
615  0$aCell culture$xTesting.
615  0$aDonation of organs, tissues, etc.$xTesting.
615  0$aCommunicable diseases$xPrevention.
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698838703321
996   $aGuidance for industry$93434577
997   $aUNINA